The explosion of generative AI in the workplace has created a new and largely unaddressed category of litigation risk. In May 2025, a federal court in the Southern District of New York ordered OpenAI to preserve and segregate all ChatGPT
McGuireWoods LLP
McGuireWoods, one of the world’s leading law firms, has earned the loyalty of its many longstanding clients with deep and broad legal experience; a passion for understanding their businesses and markets; innovative delivery of practical, business-minded solutions; and unmatched service. With 1,100 lawyers in 21 offices worldwide, McGuireWoods’ continuing success comes down to one simple fact: The firm listens to its clients.
Latest from McGuireWoods LLP - Page 4
Healthcare & Life Sciences Private Equity Deal Tracker: Altaris to Acquire Clarivate’s Life Sciences & Healthcare Business
Altaris has announced it will acquire the Life Sciences & Healthcare business (LS&H) from Clarivate (NYSE: CLVT) for $600 million.
LS&H is comprised of the Cortellis and Decision Resources Group portfolios. LS&H is an AI-enabled data intelligence products and…
Parent Company Beware: Subsidiaries’ Fidelity Bond Claims May Belong to FDIC in Receivership
In March 2023, we wrote about the failure of Silicon Valley Bank (“SVB”) and potential implications of its takeover by the Federal Deposit Insurance Company (“FDIC”). As we noted then, the FDIC, as receiver for SVB, has broad discretion…
Med Spa Growth and Capital Strategy, With Amanda Blank
Amanda Blank, CEO of Founders Beauty Group, joins McGuireWoods partner and host Geoff Cockrell to discuss the growth of her strategic med spa platform, built on a hub-and-spoke model across four geographies through the acquisition of established, doctor-owned,…
Healthcare & Life Sciences Private Equity Deal Tracker: Peak Rock Acquires Asembia
An affiliate of Peak Rock Capital has acquired Asembia, according to a news release.
Asembia, founded in 2005 and based in Florham Park, New Jersey, is a provider of technology enabled commercialization solutions for specialty pharma to pharmaceutical…
When Your D&O Insurer Wants Its Money Back — With Interest
Most policyholders purchasing directors and officers (D&O) liability insurance never contemplate the possibility that their insurer will one day demand repayment of advanced defense costs, let alone seek interest on top of repayment. Although many D&O policies preserve an insurer’s…
Healthcare & Life Sciences Private Equity Deal Tracker: Martis Acquires Deerfield Group
Martis Capital has announced it has acquired a majority stake in Deerfield Group.
Deerfield Group, founded in 2013 and based in Conshohocken, Pennsylvania, is a marketing, communications and media partner for the healthcare and life sciences sectors.
California Court Rules Automated License Plate Recognition Law Requires Actual Harm
On July 20, 2026, the California Court of Appeal (Fourth Appellate District, Division One) issued its decision in Mata v. Digital Recognition Network, Inc., No. D084781, holding that standing to sue under California’s Automated License Plate Recognition (ALPR) statute…
RWI in Practice: A 7-Part Series for Deal Professionals
PART 3: Tips for Negotiating Key Policy Terms
Introduction
Representations and warranties insurance policies are often viewed as relatively standardized products. While many policies share common structures and core provisions, important differences frequently exist beneath the surface. As a result,…
The Thaw Has Arrived in Provider Services M&A, With J. Kyle Brown
The provider services M&A market is probably approaching 50% of peak deal volume — well below historical norms — yet J. Kyle Brown sees real momentum building. Kyle is managing director and lead of the provider services group at…